Definitive Contract HHSD200201691952C
Award Date 9/12/16
Potential Completion Date 9/19/18
Potential Value $372K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,205,550.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York to provide support for translational and operational science and technology to improve the CDC. The contract has an ultimate completion date of September 12, 2024 and was awarded on September 13, 2022. This contract is not set aside. Columbia University, a leading academic research institution, will leverage...
- This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The $94,591.05 delivery order is for biomedical research services and does not have a set-aside designation. The contract is a type of Indefinite Delivery Vehicle (IDV) that allows the CDC to continuously...
- The Centers for Disease Control and Prevention (CDC) awarded a $246,462 firm-fixed-price purchase order to The Trustees of Columbia University in the City of New York, Health Sciences Division, to conduct a MPOX self-collection study. The contract has a period of performance through September 14, 2024 and does not have a set-aside designation. Columbia University is a private university and non-profit organization with extensive experience conducting biomedical research and providing services to...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $481,380.00 firm fixed-price definitive contract to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, to perform a "Prospective Assessment of Neurologic Manifestations of SARS-CoV-2 Infection in Hospitalized Patients." The contract does not have a set-aside designation and is scheduled for completion by August 31, 2023. As a...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a private university and non-profit organization. The $499,857 Delivery Order is part of the CDC's Clinical Immunization Safety Assessment (CISA) indefinite delivery contract, which supports ongoing monitoring and evaluation of vaccine safety as part of the agency's disease prevention...
- The Centers for Disease Control and Prevention awarded a $154,876 delivery order contract to The Trustees of Columbia University in New York, New York. The contract supports research entitled "TB in the U.S.: Epidemiology and Prevention Opportunities" through September 14, 2010. As a private, non-profit educational institution, Columbia University will provide subject matter expertise and analysis to the CDC regarding tuberculosis trends, transmission dynamics, and strategies for...
- This federal contract award to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, is for a Pediatric COVID-19 Vaccination Randomized Controlled Trial (RCT). The award, valued at $730,877, was made by the Centers for Disease Control and Prevention (CDC) under the Clinical Immunization Safety Assessment (CISA) contract vehicle. The contract has a period of performance ending on December 28, 2025. There is no set-aside designation for this...
- This is a delivery order contract awarded to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, by the Centers for Disease Control and Prevention (CDC). The $774,425 contract is for the CISA RSV INFANTS STUDY (CONTRIBUTING SITE) and does not have a set-aside designation. The contract is a cost-no-fee type with a period of performance through September 26, 2027. As a leading research institution, Columbia University has extensive...
- The Centers for Disease Control and Prevention (CDC) awarded a delivery order valued at $300,905 to The Trustees of Columbia University in the City of New York (Health Sciences Division) on September 28, 2023, for Clinical Immunization Safety Assessment (CISA) services. This delivery order falls under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a potential ceiling value of $86 million extending through September 27, 2028. The contract utilizes a cost-no-fee pricing...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $749,000 firm fixed price contract to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, awarded on March 30, 2022, is for the VirCapSeq: A Platform for Detection of Pandemic Threats and Differential Diagnosis of Infectious Diseases project under AOI #10 NGS-Based Agnostic Diagnostic, with a completion date...